Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy
- Supplementary File 1:
ZIP-Document (ZIP, 307 KiB)
Ortega-García, M.B.; Mesa, A.; Moya, E.L.J.; Rueda, B.; Lopez-Ordoño, G.; García, J.Á.; Conde, V.; Redondo-Cerezo, E.; Lopez-Hidalgo, J.L.; Jiménez, G.; Peran, M.; Martínez-González, L.J.; del Val, C.; Zwir, I.; Marchal, J.A.; García, M.Á. Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy. Cancers 2020, 12, 379. https://doi.org/10.3390/cancers12020379
Ortega-García MB, Mesa A, Moya ELJ, Rueda B, Lopez-Ordoño G, García JÁ, Conde V, Redondo-Cerezo E, Lopez-Hidalgo JL, Jiménez G, Peran M, Martínez-González LJ, del Val C, Zwir I, Marchal JA, García MÁ. Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy. Cancers. 2020; 12(2):379. https://doi.org/10.3390/cancers12020379
Chicago/Turabian StyleOrtega-García, María B., Alberto Mesa, Elisa L.J. Moya, Beatriz Rueda, Gabriel Lopez-Ordoño, Javier Á. García, Verónica Conde, Eduardo Redondo-Cerezo, Javier L. Lopez-Hidalgo, Gema Jiménez, Macarena Peran, Luis J. Martínez-González, Coral del Val, Igor Zwir, Juan A. Marchal, and María Á. García. 2020. "Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy" Cancers 12, no. 2: 379. https://doi.org/10.3390/cancers12020379